Research Article
Exploring the Antitumor Mechanisms of Zingiberis Rhizoma Combined with Coptidis Rhizoma Using a Network Pharmacology Approach
Table 4
Affinity test between component and tumor target using surface plasmon resonance (SPR) assay.
| Ligand name | Analyte name | Analyte concentration | Relative response (RU) |
| AKT1 | Berberine | 1 μM | -1.7 | 10 μM | 4.6 | 100 μM | 63.8 |
| TP53 | Berberine | 1 μM | 0.8 | 10 μM | 3.4 | 100 μM | 22.7 |
| EGFR | Quercetin | 1 μM | 5.8 | 10 μM | 12.4 | 100 μM | 77.0 |
| VEGF165 | Ginkgetin | 1 μM | 1.0 | 10 μM | 1.3 | 100 μM | 3.7 |
| VEGF165 | Isoginkgetin | 1 μM | 0.3 | 10 μM | 2.2 | 100 μM | 3.3 |
| VEGF165 | Daucosterol | 1 μM | 0.0 | 10 μM | 0.5 | 100 μM | 2.0 |
| VEGF165 | Quercetin | 1 μM | 2.5 | 10 μM | 3.5 | 100 μM | 12.1 |
|
|